Transplantation of Human Neural Progenitor Cells (NPC) into Putamina of Parkinsonian Patients: A Case Series Study, Safety and Efficacy Four Years after Surgery.

导出 OA

翻译打印收藏纠错

作者： I,Madrazo ^[1] ; O,Kopyov ^[2] ; M A,Ávila-Rodríguez ^[3] ; F,Ostrosky ^[4] ; H,Carrasco ^[5] ; A,Kopyov ^[2] ; A,Avendaño-Estrada ^[3] ; F,Jiménez ^[6] ; E,Magallón ^[7] ; C,Zamorano ^[6] ; G,González ^[7] ; T,Valenzuela ^[6] ; R,Carrillo ^[7] ; F,Palma ^[4] ; R,Rivera ^[6] ; R E,Franco-Bourland ^[7] ; G,Guízar-Sahagún ^[6]

作者单位： 1 Hospital General de México "Dr. Eduardo Liceaga", Mexico City, Mexico. ^[1] 2 Celavie Biosciences LLC, Oxnard, CA, USA. ^[2] 3 Unidad Radiofarmacia-Ciclotron, Facultad de Medicina, Universidad Nacional Autonoma de Mexico, Mexico City, Mexico. ^[3] 4 Facultad de Psicología, Universidad Nacional Autonoma de Mexico, Mexico City, Mexico. ^[4] 5 Hospital Central Militar, Mexico City, Mexico. ^[5] 6 Hospital Angeles Pedregal, Mexico City, Mexico. ^[6] 7 Neuroscience Center, Hospital Angeles Pedregal, Mexico City, Mexico. ^[7] 8 Department of Biochemistry, Instituto Nacional de Rehabilitación Luis Guillermo Ibarra Ibarra, Mexico City, Mexico. ^[8] 9 Centro Medico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City, Mexico. ^[9]

关键词 PET molecular imaging Parkinson’s disease human neural progenitor cells stem cell transplantation stereotactic surgery